# TFAP4

## Overview
TFAP4, or transcription factor AP-4, is a gene that encodes a basic helix-loop-helix leucine zipper transcription factor involved in the regulation of gene expression. The protein product, transcription factor AP-4, plays a pivotal role in various cellular processes, including cell proliferation, cell cycle regulation, and cellular senescence. It functions by binding to E-box sequences in DNA, thereby modulating the expression of target genes. This transcription factor is intricately linked to the oncogene c-MYC, influencing c-MYC-driven cellular activities, particularly in the maturation of B cells within germinal centers. TFAP4's interactions with other proteins and its involvement in key signaling pathways underscore its significance in both normal cellular functions and pathological conditions, such as cancer, where it serves as a potential biomarker and therapeutic target (Wong2021Transcription; Potts2022Deletion; Song2018Transcription).

## Structure


## Function
TFAP4, also known as transcription factor AP-4, is a basic helix-loop-helix leucine zipper transcription factor that plays a significant role in regulating gene expression in healthy human cells. It is involved in several cellular processes, including cell proliferation, cell cycle control, and cellular senescence. TFAP4 functions by binding to E-box sequences in DNA, which allows it to either activate or repress target gene expression. This transcription factor is directly regulated by the oncogene c-MYC and is critical for c-MYC-driven proliferation and maturation of B cells in germinal centers following an infectious challenge (Potts2022Deletion).

In the context of B cell differentiation, TFAP4 is essential for the proper maturation of B cells. It regulates the expression of key transcription factors necessary for B cell differentiation, such as Ikzf1, Ikzf3, Spi1, SpiB, and Pax5. The absence of TFAP4 impairs this differentiation process, leading to an accumulation of proliferative pre-B cells, which can contribute to oncogenic transformation (Potts2022Deletion). TFAP4 is active in the nucleus, where it influences various molecular processes that are crucial for maintaining normal cellular functions and immune responses (Potts2022Deletion).

## Clinical Significance
Alterations in the expression of the TFAP4 gene have significant clinical implications across various cancer types. In colorectal cancer (CRC), TFAP4 is involved in DNA damage response and chromosomal stability. Loss of TFAP4 leads to increased DNA damage, chromosomal instability, and cellular senescence, which are associated with reduced cell viability and increased apoptosis. This suggests that TFAP4 plays a crucial role in maintaining genomic stability and its dysregulation could impact CRC progression and treatment resistance (Chou2022AP4).

In prostate cancer, TFAP4 is upregulated and associated with poor prognosis, including shorter overall survival. It promotes cancer cell viability, invasion, and migration by regulating the expression of FOXK1, a gene involved in cancer progression (Gu2021TFAP4).

TFAP4 is also implicated in hepatocellular carcinoma (HCC) through the activation of the Wnt/β-catenin signaling pathway, enhancing tumorigenicity and cancer cell stemness (Song2018Transcription). In non-small cell lung cancer (NSCLC), TFAP4 expression is linked to poor prognosis and lymph node metastasis, and its regulation by miR-608 affects sensitivity to chemotherapy (Wang2019MicroRNA608).

Overall, TFAP4 serves as a prognostic biomarker and potential therapeutic target in multiple cancers due to its role in promoting tumor progression and metastasis (Liu2020An; Wong2021Transcription).

## Interactions
TFAP4, a transcription factor, engages in various interactions with proteins and nucleic acids that influence its regulatory functions. It forms homodimers and binds to specific DNA motifs, primarily the E-box motif, to regulate gene expression (Wong2021Transcription). TFAP4 interacts with several proteins, including c-Myc and N-Myc, which are involved in feedback loops that control its levels and functions (Wong2021Transcription). It also interacts with p53, lncRNAs, and miRNAs, forming complexes that modulate its activity (Wong2021Transcription).

TFAP4 acts as a transcriptional repressor by forming complexes with proteins such as histone deacetylase 1 (HDAC1) and transcription corepressor geminin (Gem), which are involved in gene repression (Wong2021Transcription). It recruits chromatin-modifying enzymes, including histone deacetylases (HDACs) and histone methyltransferases, to mediate its repressive functions (Wong2021Transcription).

In glioma cells, TFAP4 is part of a feedback loop involving LINC00520 and miR-520f-3p, which modulates its expression and impacts cell behaviors (Wang2020Transcription). TFAP4 also interacts with the Wnt/β-catenin signaling pathway, directly targeting and regulating genes like DVL1 and LEF1, which are crucial for its role in cancer progression (Song2018Transcription).


## References


[1. (Liu2020An) Jian‐Nan Liu, Xiang‐Shuo Kong, Ping Sun, Rui Wang, Wang Li, and Qi‐Feng Chen. An integrated pan‐cancer analysis of tfap4 aberrations and the potential clinical implications for cancer immunity. Journal of Cellular and Molecular Medicine, 25(4):2082–2097, December 2020. URL: http://dx.doi.org/10.1111/jcmm.16147, doi:10.1111/jcmm.16147. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.16147)

[2. (Gu2021TFAP4) Yuan Gu, Jiujin Jiang, and Chaozhao Liang. Tfap4 promotes the growth of prostate cancer cells by upregulating foxk1. Experimental and Therapeutic Medicine, September 2021. URL: http://dx.doi.org/10.3892/etm.2021.10734, doi:10.3892/etm.2021.10734. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2021.10734)

[3. (Wang2020Transcription) Yipeng Wang, Chunqing Yang, Xiaobai Liu, Jian Zheng, Fangfang Zhang, Di Wang, Yixue Xue, Xiaozhi Li, Shuyuan Shen, Lianqi Shao, Yang Yang, Libo Liu, Jun Ma, and Yunhui Liu. Transcription factor ap‐4 (tfap4)‐upstream orf coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the tfap4/long noncoding rna 00520/microrna‐520f‐3p feedback loop. Cancer Science, 111(3):891–906, February 2020. URL: http://dx.doi.org/10.1111/cas.14308, doi:10.1111/cas.14308. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cas.14308)

[4. (Chou2022AP4) Jinjiang Chou, Markus Kaller, Stephanie Jaeckel, Matjaz Rokavec, and Heiko Hermeking. Ap4 suppresses dna damage, chromosomal instability and senescence via inducing mdc1/mediator of dna damage checkpoint 1 and repressing mir22hg/mir-22-3p. Molecular Cancer, May 2022. URL: http://dx.doi.org/10.1186/s12943-022-01581-1, doi:10.1186/s12943-022-01581-1. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-022-01581-1)

[5. (Song2018Transcription) Junwei Song, Chan Xie, Lili Jiang, Geyan Wu, Jinrong Zhu, Shuxia Zhang, Miaoling Tang, Libing Song, and Jun Li. Transcription factor ap-4 promotes tumorigenic capability and activates the wnt/β-catenin pathway in hepatocellular carcinoma. Theranostics, 8(13):3571–3583, 2018. URL: http://dx.doi.org/10.7150/thno.25194, doi:10.7150/thno.25194. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.25194)

6. (Potts2022Deletion) Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis. This article has 0 citations.

[7. (Wong2021Transcription) Matthew Man-Kin Wong, Sancy Mary Joyson, Heiko Hermeking, and Sung Kay Chiu. Transcription factor ap4 mediates cell fate decisions: to divide, age, or die. Cancers, 13(4):676, February 2021. URL: http://dx.doi.org/10.3390/cancers13040676, doi:10.3390/cancers13040676. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13040676)

[8. (Wang2019MicroRNA608) Yi-Fei Wang, Xiang Ao, Ying Liu, Dan Ding, Wen-Jie Jiao, Zhuang Yu, Wen-Xin Zhai, Sheng-Hua Dong, Yu-Qi He, Hang Guo, and Jian-Xun Wang. Microrna-608 promotes apoptosis in non-small cell lung cancer cells treated with doxorubicin through the inhibition of tfap4. Frontiers in Genetics, September 2019. URL: http://dx.doi.org/10.3389/fgene.2019.00809, doi:10.3389/fgene.2019.00809. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2019.00809)